University of Oxford
University Offices
Wellington Square
Oxford
England
OX1 2JD
United Kingdom
Website: http://www.ox.ac.uk/index.html
242 articles about University of Oxford
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 10, 2020.
-
The Oxford and AstraZeneca co-developed COVID-19 vaccine could be one of the first vaccines submitted for regulatory approval, alongside Pfizer and BioNTech’s vaccine candidate BNT162b2.
-
Clinical Catch-Up: September 14-18
9/21/2020
It was a fairly busy week for clinical trial announcements, with some important and interesting news about COVID-19 treatments and vaccines, as well as numerous stories about non-COVID-19 studies. -
Research published in Lancet Oncology August 24th analyzed that risk by tumor subtype and patient demographics, looking at 1,044 patients from 60 medical centers throughout the UK.
-
ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer
8/27/2020
ViewRay, the GenesisCare Foundation and the Pancreatic Cancer Research Fund Work Together to Provide MRIdian Radiation Therapy at No Cost to NHS Pancreatic Cancer Patients
-
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
8/24/2020
Catalent, Inc. announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19 vaccine, AZD1222, at Catalent’s commercial gene therapy manufacturing facility located in Harmans, Maryland.
-
Clinical Catch-Up: July 20-24
7/27/2020
It was a busy week for clinical trial news, with some very important early-stage trial data for various COVID-19 vaccines. Here’s a look. -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 3, 2020.
-
New Capture the Fracture® Partnership Aims for 25% Reduction in the Incidence of Hip and Vertebral Fractures Due to Osteoporosis by 2025
6/16/2020
International Osteoporosis Foundation Announces First-of-its-kind Partnership With University of Oxford, Amgen and UCB to Combat Global Public Health Burden of Osteoporosis
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
-
The U.S. Biomedical Advanced Research and Development Authority (BARDA) paid more than $1 billion to support the development, production and delivery of the vaccine beginning this fall.
-
Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate
4/30/2020
Vaccitech Ltd and the University of Oxford announce an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 30, 2020.
-
AstraZeneca and the University of Oxford have partnered on the global development and distribution of Oxford’s COVID-19 vaccine it is developing.
-
Clinical Catch-Up: April 20-24
4/27/2020
Despite the domination of the news cycle by the COVID-19 pandemic, quite a number of biopharma companies reported on non-COVID-19 clinical trials last week, although there remains plenty of ongoing trial news related to the pandemic. Here’s a look. -
Standard International and Elysium Health™ Announce Science-Backed Wellness Partnership
10/30/2019
With a shared commitment to innovation, the alliance aims to support a healthier humanity--starting with healthier guests
-
New insight into microRNA function can give gene therapy a boost
7/17/2019
Scientists at the University of Eastern Finland and the University of Oxford have shown that small RNA molecules occurring naturally in cells, i.e. microRNAs, are also abundant in cell nuclei.
-
Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study
7/9/2019
Blue Water Vaccines, a company developing a universal flu vaccine based on technology developed at the University of Oxford, has closed a $7 million seed capital round led by CincyTech.